-
IGF2BP3, m6A, and Ferroptosis in Glioma
2026-09-29
This Cell Death and Disease study identifies IGF2BP3 as an m6A-dependent regulator of GPX4 expression and ferroptosis in glioma. Its experiments connect RNA modification, transcript stability, tumor formation, and microglial phagocytosis, providing a mechanistic framework for studying post-transcriptional control of glioma survival.
-
Neticonazole Hydrochloride Research Workflows
2026-09-29
Neticonazole Hydrochloride supports two distinct experimental tracks: fungal susceptibility and exploratory colorectal cancer research. This guide connects practical assay design, formulation considerations, exosome and apoptosis readouts, and troubleshooting without treating preclinical oncology findings as established clinical use.
-
GW4064: A Causal Probe of FXR in Cholestasis
2026-09-28
GW4064 is a selective non-steroidal FXR agonist for dissecting bile acid efflux, lipid regulation, and cholestatic injury. This article presents an assay-centered framework linking FXR activation to BSEP, MRP2, tight-junction integrity, and interpretation of toxicology findings.
-
SN-38 Disrupts FUBP1–FUSE Binding: Study Insights
2026-09-28
A 2017 study found that camptothecin and SN-38 can inhibit the binding of the oncogenic transcriptional regulator FUBP1 to its DNA target FUSE in vitro, with associated changes in FUBP1-regulated gene expression in hepatocellular carcinoma cells. The findings suggest a potential additional mechanism alongside topoisomerase I inhibition, while leaving its contribution to cellular and clinical responses unresolved.
-
Staurosporine: Practical Workflows for Cancer Research
2026-09-27
Use Staurosporine to establish apoptosis benchmarks and interrogate kinase-dependent signaling—while keeping its broad activity distinct from a selective mechanistic probe. A practical dose-and-time workflow, paired with matrix-aware assay design, helps make cancer-cell results more interpretable.
-
AMPK restrains autophagy during energy stress
2026-09-26
Park, Lee, and Kim challenge the prevailing view that AMPK generally activates autophagy during glucose shortage. Their findings show that AMPK can suppress ULK1 signaling during energy stress while helping preserve autophagy machinery, separating immediate pathway activity from the cell’s capacity to recover later.
-
Propranolol for Essential Tremor Research
2026-09-25
Use Propranolol to probe β-adrenergic blockade across peripheral and central tremor-related workflows, while keeping mechanistic claims tied to measured outcomes. A 2024 TMS study offers a practical translational framework: pair tremor assessment with corticospinal excitability and short afferent inhibition rather than relying on tremor scores alone.
-
Sulfo-Cy5 carboxylic acid for nanoparticle assays
2026-09-25
Use this water-compatible far-red dye to build fluorescence readouts for nanoparticle-associated cargo, labeled biomolecules, and tissue imaging—while distinguishing cargo release from particle movement. The workflow explains when the non-activated carboxylic acid is appropriate, when an NHS ester is a better choice, and how to validate signal before interpreting biological targeting.
-
S Tag Peptide: Practical Fusion Tag Workflow
2026-09-24
S Tag Peptide supports recombinant protein detection and can be incorporated into fusion-tag workflows where protein solubility improvement or antibody-based detection is needed. The supplied peptide is water- and DMSO-soluble but ethanol-insoluble; use a genetically encoded S-peptide fusion tag for recombinant expression, and do not assume the free peptide alone provides a complete purification or expression solution.
-
Neticonazole Hydrochloride in Cell Assay Workflows
2026-09-24
This scenario-led guide explains how to evaluate Neticonazole Hydrochloride (SKU C8715) in viability, proliferation, cytotoxicity, antifungal, and exploratory colorectal cancer research. It separates documented product properties from workflow suggestions and highlights assay controls, solubility, storage, and evidence limitations.
-
ROCK Inhibition as a Translational Control Point
2026-09-23
Y-27632 dihydrochloride offers researchers a selective way to perturb ROCK signaling, but its greatest value comes from pairing mechanistic control with careful model design. This article connects cytoskeletal biology to stem-cell and cancer research, using schizophrenia iPSC lines to illustrate both the promise and limits of translational model building.
-
BMAL1 Phase Separation in Circadian Transcription
2026-09-23
Gao et al. identify BMAL1 as a phase-separating clock factor whose N-terminal intrinsically disordered region organizes dynamic nuclear condensates. These condensates recruit CLOCK and transcriptional cofactors at E-box DNA, linking BMAL1 organization to rhythmic transcription and behavioral timing.
-
Cisplatin Assays: From DNA Damage to Resistance
2026-09-22
Cisplatin and CDDP remain powerful tools for cancer research, but assay interpretation depends on separating DNA damage from compensatory survival signaling. This guide translates a cisplatin-resistant lung cancer study into practical, resistance-aware experimental design.
-
Hyperthermia Sensitizes BRCA2-Proficient Ovarian Cancer
2026-09-22
Mei et al. show that hyperthermia can reduce BRCA2 protein and increase niraparib sensitivity in BRCA2-proficient ovarian carcinoma models. The study provides a mechanistic rationale for combining thermal treatment with PARP inhibition to extend synthetic-lethal strategies beyond tumors with pre-existing BRCA2 defects.
-
MK-4827 (Niraparib) Workflow for PARP Studies
2026-09-21
Build reproducible PARP-inhibitor assays with MK-4827 (Niraparib), from BRCA-mutant benchmarking to hyperthermia-sensitized ovarian cancer models. This workflow links DNA damage repair inhibition to practical viability, apoptosis, and RAD51-foci readouts while highlighting controls that expose resistance mechanisms.